FDA Approved: ALFUZOSIN HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Alfuzosin Hydrochloride Extended Release by Cipla USA Inc., approving changes to the marketed product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• ALFUZOSIN HYDROCHLORIDE EXTENDED RELEASE (alfuzosin hydrochloride extended-release)

Snippet

SUPPL AP for ALFUZOSIN HYDROCHLORIDE EXTENDED RELEASE (ALFUZOSIN HYDROCHLORIDE)